Katherine Stueland Sema4 Holdings Corp. (SMFR) insider trading activity

Katherine Stueland is Chief Executive Officer of Sema4 Holdings Corp.. Currently has a direct ownership of 103,706 shares of SMFR, which is worth approximately $35,260. The most recent transaction as insider was on Sep 16, 2024, when has been sold 10,501 shares (Class A Common Stock) at a price of $37.59 per share, resulting in proceeds of $394,732. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K

14.18% 3M change

142.93% 12M change

Total Value Held $35,260

Katherine Stueland Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 16 2024	SELL Open market or private sale	$394,732 $37.59 p/Share	10,501 Reduced 9.19%	103,706 Class A Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	-	18,750 Added 14.1%	114,207 Class A Common Stock
Sep 09 2024	SELL Open market or private sale	$121,287 $33.33 p/Share	3,639 Reduced 3.67%	95,457 Class A Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	-	6,546 Added 6.2%	99,096 Class A Common Stock
Jul 29 2024	SELL Open market or private sale	$72,245 $33.54 p/Share	2,154 Reduced 2.27%	92,550 Class A Common Stock
Jul 29 2024	BUY Exercise of conversion of derivative security	-	3,874 Added 3.93%	94,704 Class A Common Stock
Jun 17 2024	SELL Open market or private sale	$217,505 $28.31 p/Share	7,683 Reduced 7.8%	90,830 Class A Common Stock
Jun 16 2024	BUY Exercise of conversion of derivative security	-	18,750 Added 15.99%	98,513 Class A Common Stock
Jun 10 2024	SELL Open market or private sale	$66,087 $24.92 p/Share	2,652 Reduced 3.22%	79,763 Class A Common Stock
Jun 09 2024	BUY Exercise of conversion of derivative security	-	6,546 Added 7.36%	82,415 Class A Common Stock
Apr 29 2024	SELL Open market or private sale	$69,828 $11.04 p/Share	6,325 Reduced 7.7%	75,869 Class A Common Stock
Apr 29 2024	BUY Exercise of conversion of derivative security	-	15,496 Added 15.86%	82,194 Class A Common Stock
Mar 18 2024	SELL Open market or private sale	$90,639 $10.59 p/Share	8,559 Reduced 11.37%	66,698 Class A Common Stock
Mar 16 2024	BUY Exercise of conversion of derivative security	-	18,750 Added 19.95%	75,257 Class A Common Stock
Mar 12 2024	SELL Open market or private sale	$24,111 $9.21 p/Share	2,618 Reduced 4.43%	56,507 Class A Common Stock
Mar 09 2024	BUY Exercise of conversion of derivative security	-	6,547 Added 9.97%	59,125 Class A Common Stock
Dec 18 2023	SELL Open market or private sale	$25,345 $2.16 p/Share	11,734 Reduced 18.25%	52,578 Class A Common Stock
Dec 16 2023	BUY Exercise of conversion of derivative security	-	18,750 Added 22.57%	64,312 Class A Common Stock
Dec 11 2023	SELL Open market or private sale	$5,913 $1.61 p/Share	3,673 Reduced 7.46%	45,562 Class A Common Stock
Dec 09 2023	BUY Exercise of conversion of derivative security	-	6,546 Added 11.74%	49,235 Class A Common Stock
Sep 18 2023	SELL Open market or private sale	$44,728 $4.16 p/Share	10,752 Reduced 20.12%	42,689 Class A Common Stock
Sep 16 2023	BUY Exercise of conversion of derivative security	-	18,750 Added 25.97%	53,441 Class A Common Stock
Sep 11 2023	SELL Open market or private sale	$12,358 $4.62 p/Share	2,675 Reduced 7.16%	34,691 Class A Common Stock
Sep 09 2023	BUY Exercise of conversion of derivative security	-	6,547 Added 14.91%	37,366 Class A Common Stock
Jun 20 2023	SELL Open market or private sale	$50,577 $6.35 p/Share	7,965 Reduced 20.54%	30,819 Class A Common Stock

Also insider at

NVTA

Invitae Corp Healthcare

Chief Commercial Officer